← Holders
Ally Bridge Group (NY) LLC
What Ally Bridge Group (NY) LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1822947 · Filed Nov 16, 2026
- Positions
- 18
- Reported value
- $76M
- Opened
- 6
- Closed
- 13
- Other managers included
- 1
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$164.2M24 positions
- Dec 31, 2025$96M18 positions
- Mar 31, 2026$123.8M27 positions
- Jun 30, 2026$113.1M25 positions
- Sep 30, 2026$76M18 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
| 400K | ±0% | $15.2M | 20% | |
| 125K | ±0% | $12.4M | 16.3% | |
EWTXEdgewise Therapeutics, Inc. | 185.4K | +122.6% | $7.5M | 9.9% |
PMNProMIS Neurosciences Inc. | 620.3K | ±0% | $6.7M | 8.9% |
NERVMinerva Neurosciences, Inc. | 1.7M | −23.9% | $5.5M | 7.3% |
AMLXAmylyx Pharmaceuticals, Inc. | 182K | New | $5.3M | 7% |
STTKShattuck Labs, Inc. | 625.2K | New | $4.3M | 5.6% |
OBXObsidian Therapeutics, Inc. | 302.4K | New | $4.2M | 5.5% |
| 400K | New | $3M | 3.9% | |
ANTXAN2 Therapeutics, Inc. | 526.3K | ±0% | $2.8M | 3.7% |
EPRXEupraxia Pharmaceuticals Inc. | 231.1K | −8.3% | $2.1M | 2.8% |
| 2M | New | $2.1M | 2.7% | |
AVTXAvalo Therapeutics, Inc. | 134.4K | −10.4% | $2.1M | 2.7% |
IVAInventiva S.A. | 227.3K | −64.2% | $838.6K | 1.1% |
VOGXVogenx, Inc. | 32.7K | New | $745.3K | 1% |
TRAWTraws Pharma, Inc. | 786.2K | ±0% | $466.9K | 0.6% |
CATXPerspective Therapeutics, Inc. | 163.6K | −78.0% | $450K | 0.6% |
ASMBAssembly Biosciences, Inc. | 18.3K | −86.9% | $429.8K | 0.6% |